128 related articles for article (PubMed ID: 19711841)
1. [Methodic approaches to testing Bacillus anthracis susceptibility to antibacterials].
Buravtseva NP; Aksenova LIu; Riazanova AG
Antibiot Khimioter; 2009; 54(3-4):6-10. PubMed ID: 19711841
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility to antibiotics of Bacillus anthracis strains isolated in Romania.
Caplan DM; Ivana S; Caplan ME
Roum Arch Microbiol Immunol; 2009; 68(2):106-10. PubMed ID: 20361530
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of Bacillus anthracis strains from Hungary.
Kreizinger Z; Sulyok KM; Makrai L; Rónai Z; Fodor L; Jánosi S; Gyuranecz M
Acta Vet Hung; 2016 Jun; 64(2):141-7. PubMed ID: 27342086
[TBL] [Abstract][Full Text] [Related]
4. [Comparative evaluation of methods for determining the sensitivity of the anthrax microbe to antibiotics].
Proskurina VA; Buravtseva NP
Antibiot Med Biotekhnol; 1985 Nov; 30(11):845-7. PubMed ID: 3937488
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study on the sensitivity of Bac. anthracis to various antibiotics].
Buravtseva NP; Kuleshova LI
Antibiotiki; 1971 Nov; 16(11):1019-23. PubMed ID: 5004535
[No Abstract] [Full Text] [Related]
6. Selection of Bacillus anthracis isolates resistant to antibiotics.
Athamna A; Athamna M; Abu-Rashed N; Medlej B; Bast DJ; Rubinstein E
J Antimicrob Chemother; 2004 Aug; 54(2):424-8. PubMed ID: 15205405
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare.
Jones ME; Goguen J; Critchley IA; Draghi DC; Karlowsky JA; Sahm DF; Porschen R; Patra G; DelVecchio VG
Clin Microbiol Infect; 2003 Sep; 9(9):984-6. PubMed ID: 14616693
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Bacillus anthracis and potential surrogate bacilli growth from spore inocula by nisin and other antimicrobial peptides.
Montville TJ; De Siano T; Nock A; Padhi S; Wade D
J Food Prot; 2006 Oct; 69(10):2529-33. PubMed ID: 17066940
[TBL] [Abstract][Full Text] [Related]
9. Improvement of a selective media for the isolation of B. anthracis from soils.
Luna VA; Gulledge J; Cannons AC; Amuso PT
J Microbiol Methods; 2009 Dec; 79(3):301-6. PubMed ID: 19808058
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Bacillus anthracis to eleven antimicrobial agents including novel fluoroquinolones and a ketolide.
Frean J; Klugman KP; Arntzen L; Bukofzer S
J Antimicrob Chemother; 2003 Aug; 52(2):297-9. PubMed ID: 12865385
[TBL] [Abstract][Full Text] [Related]
11. Etest for antibiotic susceptibility testing of Bacillus anthracis, Bacillus cereus and Bacillus thuringiensis: evaluation of a French collection.
Mérens A; Vaissaire J; Cavallo JD; Le Doujet C; Gros C; Bigaillon C; Paucod JC; Berger F; Valade E; Vidal D
Int J Antimicrob Agents; 2008 May; 31(5):490-2. PubMed ID: 18316178
[No Abstract] [Full Text] [Related]
12. Optical Screening for Rapid Antimicrobial Susceptibility Testing and for Observation of Phenotypic Diversity among Strains of the Genetically Clonal Species Bacillus anthracis.
McLaughlin HP; Gargis AS; Michel P; Sue D; Weigel LM
J Clin Microbiol; 2017 Mar; 55(3):959-970. PubMed ID: 28053211
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of
Manzulli V; Fasanella A; Parisi A; Serrecchia L; Donatiello A; Rondinone V; Caruso M; Zange S; Tscherne A; Decaro N; Pedarra C; Galante D
J Vet Sci; 2019 Jan; 20(1):58-62. PubMed ID: 30541185
[TBL] [Abstract][Full Text] [Related]
14. Is in vitro antibiotic combination more effective than single-drug therapy against anthrax?
Athamna A; Athamna M; Nura A; Shlyakov E; Bast DJ; Farrell D; Rubinstein E
Antimicrob Agents Chemother; 2005 Apr; 49(4):1323-5. PubMed ID: 15793105
[TBL] [Abstract][Full Text] [Related]
15. A rapid antimicrobial susceptibility test for Bacillus anthracis.
Weigel LM; Sue D; Michel PA; Kitchel B; Pillai SP
Antimicrob Agents Chemother; 2010 Jul; 54(7):2793-800. PubMed ID: 20439614
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads.
Joska TM; Anderson AC
Antimicrob Agents Chemother; 2006 Oct; 50(10):3435-43. PubMed ID: 17005826
[TBL] [Abstract][Full Text] [Related]
17. [New immunofluorescent method for the rapid determination of microbial antibiotic sensitivity].
D'iakov SI; Lebedeva IK; Lisin VV; Grishin GI
Antibiotiki; 1982 Oct; 27(10):761-6. PubMed ID: 6816140
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility and molecular diversity of Bacillus anthracis strains in Chad: detection of a new phylogenetic subgroup.
Maho A; Rossano A; Hächler H; Holzer A; Schelling E; Zinsstag J; Hassane MH; Toguebaye BS; Akakpo AJ; Van Ert M; Keim P; Kenefic L; Frey J; Perreten V
J Clin Microbiol; 2006 Sep; 44(9):3422-5. PubMed ID: 16954291
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000.
Cavallo JD; Ramisse F; Girardet M; Vaissaire J; Mock M; Hernandez E
Antimicrob Agents Chemother; 2002 Jul; 46(7):2307-9. PubMed ID: 12069996
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility and molecular subtyping of 55 Turkish Bacillus anthracis strains using 25-loci multiple-locus VNTR analysis.
Ortatatli M; Karagoz A; Percin D; Kenar L; Kilic S; Durmaz R
Comp Immunol Microbiol Infect Dis; 2012 Jul; 35(4):355-61. PubMed ID: 22445310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
